Von Eschenbach Defends FDA Action On Plan B During Confirmation Hearing
This article was originally published in The Pink Sheet Daily
Executive Summary
Acting commissioner defers when asked if he would accept a recess appointment to the FDA commissioner post, which would expire with the end of the next congressional season.
You may also be interested in...
Von Eschenbach Nomination Scheduled For Senate HELP Committee Vote
Senate Democrats are reviewing the nominee’s answers to their questions from an Aug. 1 hearing.
Von Eschenbach Nomination Scheduled For Senate HELP Committee Vote
Senate Democrats are reviewing the nominee’s answers to their questions from an Aug. 1 hearing.
Bush Nominates Acting NCI Chief For The Job
President George W. Bush announced Aug. 16 that he will nominate acting National Cancer Institute Director John Niederhuber to succeed Andrew von Eschenbach, who left the position to head up FDA